Germany Facility

Built in 1975 with expansive updates in 2004/2005 and acquired by Myonex in 2022, our Germany facility is based in Berlin. With a 13,056 sq. ft. warehouse and a total facility space of 20,688 sq. ft., our Berlin facility complements our United Kingdom and Denmark facilities by aiding in navigating Brexit requirements for seamless trial supply for our customers in Europe and beyond.

Facility Features

  • Full GMP & GDP Services
  • Manufacturing of investigational medicinal products
  • Primary Packaging and Labeling
  • Secondary Packaging and Labeling
  • QP Services (EU)
  • Importer of Record (IOR) into the EU
  • Import of investigational medicinal drugs
  • Direct to patient/subject delivery of commercial products and IMPs.
  • Returns and Destruction
  • Storage: -20°C, 2-8°C, 15-25°C

Authorisations & Certificates